Predictions
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
SoftBank Group
Start price
Target price
Perf. (%)
€45.65
25.06.20
25.06.20
-
26.08.20
26.08.20
17.43%
26.08.20
26.08.20
Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet